The value of serology testing to manage SARS-CoV-2 infections
- PMID: 32675201
- PMCID: PMC7366174
- DOI: 10.1183/13993003.02411-2020
The value of serology testing to manage SARS-CoV-2 infections
Abstract
Validated serology tests are a good complement for the SARS-CoV-2 RNA test, allow rapid epidemiological control and reveal immune status before and after vaccination.
Conflict of interest statement
Conflict of interest: L. Fernández-Barat has nothing to disclose. Conflict of interest: R. López-Aladid has nothing to disclose. Conflict of interest: A. Torres has nothing to disclose.
Comment on
-
Serology characteristics of SARS-CoV-2 infection after exposure and post-symptom onset.Eur Respir J. 2020 Aug 27;56(2):2000763. doi: 10.1183/13993003.00763-2020. Print 2020 Aug. Eur Respir J. 2020. PMID: 32430429 Free PMC article.
References
-
- World Health Organization www.whoint/emergencies/diseases/novel-coronavirus-2019/situation-reports Coronavirus Disease (COVID-2019) Situation Reports.
-
- Dong E, Du H, Gardner L. COVID-19 Dashboard by the Center for Systems, Science and Engineering (CSSE) at Johns Hopkins University (JHU), April 14, 2020 https://coronavirus.jhu.edu/map.html Date last accessed: 4 June, 2020.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Miscellaneous